These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20014984)

  • 21. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
    Filion KB; Pilote L; Rahme E; Eisenberg MJ
    J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulants, antiplatelets, and statins in heart failure.
    Farmakis D; Filippatos G; Lainscak M; Parissis JT; Anker SD; Kremastinos DT
    Cardiol Clin; 2008 Feb; 26(1):49-58, vi. PubMed ID: 18312905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do hybrid procedures have proven clinical utility and are they the wave of the future? : hybrid procedures have proven clinical utility and are the wave of the future.
    Shannon J; Colombo A; Alfieri O
    Circulation; 2012 May; 125(20):2492-503; discussion 2503. PubMed ID: 22615420
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
    Baber U; Akhter M; Kothari S; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 28. Challenges of antiplatelet therapy in patients who require anticoagulation.
    Henkel DM; Holmes DR
    J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
    Jaumdally R; Lip GY; Varma C
    Int J Clin Pract; 2005 Sep; 59(9):1070-81. PubMed ID: 16115184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stenting.
    Zinn A; Feit F
    Am J Cardiol; 2009 Sep; 104(5 Suppl):49C-54C. PubMed ID: 19695362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual antiplatelet therapy in coronary artery disease: a case-based approach.
    Raymond C; Menon V
    Cleve Clin J Med; 2009 Nov; 76(11):663-70. PubMed ID: 19884296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key advances in clinical cardiology.
    Connolly M; Menown IB
    Adv Ther; 2013 Apr; 30(4):369-86. PubMed ID: 23579862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Heart; 2011 Oct; 97(19):1552-9. PubMed ID: 21900584
    [No Abstract]   [Full Text] [Related]  

  • 36. [Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
    Henderson RA; Timmis AD
    G Ital Cardiol (Rome); 2012 Apr; 13(4):244-53. PubMed ID: 22495641
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
    White HD
    Am Heart J; 2011 Mar; 161(3):450-61. PubMed ID: 21392598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New study findings in cardiology. The best is the enemy of the good].
    Stiefelhagen P
    Med Monatsschr Pharm; 2010 Nov; 33(11):433-5. PubMed ID: 21166254
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
    Bhatt DL
    Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.